Your browser doesn't support javascript.
loading
Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma.
Li, Lingmei; Qi, Lisha; Qu, Tongyuan; Liu, Changxu; Cao, Lu; Huang, Qiujuan; Song, Wangzhao; Yang, Lingyi; Qi, Hui; Wang, Yalei; Gao, Bin; Guo, Yuhong; Sun, Baocun; Meng, Bin; Zhang, Bin; Cao, Wenfeng.
Afiliación
  • Li L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Qi L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Qu T; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Liu C; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Cao L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Huang Q; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Song W; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Yang L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Qi H; Department of Intensive Care Medicine, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
  • Wang Y; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Gao B; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Guo Y; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Sun B; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Meng B; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
  • Zhang B; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University, Ministry of Education, Tianjin, People's Republic of Chi
  • Cao W; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China; National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China; Tianjin's C
Am J Pathol ; 188(8): 1882-1894, 2018 08.
Article en En | MEDLINE | ID: mdl-29803834
ABSTRACT
Despite the development of various treatments, metastasis remains a significant problem with lung adenocarcinoma (ADC). The role and mechanism of epithelial splicing regulatory protein 1 (ESRP1), an epithelial-specific RNA binding protein, on promoting the invasion and metastasis of lung ADC remain to be fully elucidated. Immunohistochemical analysis in 125 human lung ADC tissue samples demonstrated that ESRP1 overexpression was inversely related to the presence of metastases, tumor size, and clinical stage of lung ADC. Impaired ESRP1 expression was also found to stimulate the invasion capacity of lung ADC cells both in vitro and in vivo. Functionally, overexpression of the ZEB1 gene decreased ESRP1 expression, and knockdown of the ZEB1 gene caused increased ESRP1 expression. On the basis of a gene array analysis, the expression of ESRP1 was associated with the regulation of the extracellular matrix. The expression of CD44 and fibroblast growth factor receptor, representatives that interact with the extracellular matrix, was studied. The CD44 subtypes promoted lung ADC cell invasion by regulating matrix metalloproteinase 2 expression. In conclusion, ESRP1 inhibits the invasion and metastasis of lung ADC and plays a role in regulating proteins involved in epithelial-to-mesenchymal transition.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Biomarcadores de Tumor / Proteínas de Unión al ARN / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Pathol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Biomarcadores de Tumor / Proteínas de Unión al ARN / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Pathol Año: 2018 Tipo del documento: Article